Jessica C. Petrov

737 total citations
22 papers, 476 citations indexed

About

Jessica C. Petrov is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Jessica C. Petrov has authored 22 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 8 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Jessica C. Petrov's work include Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (4 papers) and Inflammatory Bowel Disease (4 papers). Jessica C. Petrov is often cited by papers focused on Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (4 papers) and Inflammatory Bowel Disease (4 papers). Jessica C. Petrov collaborates with scholars based in United States, Canada and China. Jessica C. Petrov's co-authors include Anastasia Nijnik, Jad I. Belle, Yupo Ma, Lulu Yan, Kevin G. Pinz, M. Wada, Xiao Shuai, Philippe Gros, David Langlais and Xun Jiang and has published in prestigious journals such as Blood, Cell Death and Differentiation and The American Journal of Gastroenterology.

In The Last Decade

Jessica C. Petrov

18 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jessica C. Petrov United States 13 242 216 159 91 90 22 476
Rafet Başar United States 14 248 1.0× 118 0.5× 240 1.5× 35 0.4× 48 0.5× 25 465
Rui Cui China 12 179 0.7× 122 0.6× 73 0.5× 43 0.5× 143 1.6× 40 425
Giulia Mesiano Italy 14 356 1.5× 92 0.4× 346 2.2× 46 0.5× 36 0.4× 23 590
Sasan Ghaffari Iran 10 123 0.5× 117 0.5× 84 0.5× 40 0.4× 40 0.4× 21 309
Zhongxing Jiang China 13 118 0.5× 164 0.8× 113 0.7× 32 0.4× 81 0.9× 28 364
David Stroncek United States 9 233 1.0× 151 0.7× 109 0.7× 113 1.2× 36 0.4× 18 455
A. Rietz Germany 11 201 0.8× 179 0.8× 162 1.0× 26 0.3× 33 0.4× 14 411
Elham Roshandel Iran 11 101 0.4× 126 0.6× 93 0.6× 35 0.4× 100 1.1× 60 376
Saada Eid United States 10 106 0.4× 63 0.3× 119 0.7× 29 0.3× 88 1.0× 23 321
Shengkang Huang China 5 210 0.9× 106 0.5× 113 0.7× 51 0.6× 21 0.2× 8 377

Countries citing papers authored by Jessica C. Petrov

Since Specialization
Citations

This map shows the geographic impact of Jessica C. Petrov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica C. Petrov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica C. Petrov more than expected).

Fields of papers citing papers by Jessica C. Petrov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica C. Petrov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica C. Petrov. The network helps show where Jessica C. Petrov may publish in the future.

Co-authorship network of co-authors of Jessica C. Petrov

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica C. Petrov. A scholar is included among the top collaborators of Jessica C. Petrov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica C. Petrov. Jessica C. Petrov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petrov, Jessica C., et al.. (2024). Rates, Predictors, and Outcomes of Ustekinumab Dose Escalation in Inflammatory Bowel Disease. Journal of Clinical Gastroenterology. 59(3). 232–236. 3 indexed citations
2.
Petrov, Jessica C., Aakash Desai, Gursimran Kochhar, et al.. (2024). Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study. Inflammatory Bowel Diseases. 31(5). 1237–1247. 6 indexed citations
3.
Petrov, Jessica C., et al.. (2024). Ustekinumab Drug Levels and Outcomes in Inflammatory Bowel Disease. Journal of Clinical Gastroenterology. 59(1). 77–81.
4.
Desai, Aakash, Jessica C. Petrov, Jana G. Hashash, et al.. (2024). Use of glucagon‐like peptide‐1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 60(5). 620–632. 16 indexed citations
5.
Petrov, Jessica C., et al.. (2024). S3861 Infliximab-Induced Skin Eruption in a Patient With Perianal Crohn's Disease. The American Journal of Gastroenterology. 119(10S). S2522–S2522.
6.
Petrov, Jessica C., Johanna Chan, Aakash Desai, Francis A. Farraye, & Jana G. Hashash. (2023). S56 Not What it Seems: Colitis and Pseudopolyp Turn Out To Be Immune Checkpoint Inhibitor Colitis and Metastatic Renal Cell Carcinoma. The American Journal of Gastroenterology. 118(12S). S15–S16.
7.
Belle, Jad I., et al.. (2021). p53-dependent induction of P2X7 on hematopoietic stem and progenitor cells regulates hematopoietic response to genotoxic stress. Cell Death and Disease. 12(10). 923–923. 13 indexed citations
8.
Petrov, Jessica C., et al.. (2021). Gallbladder Disorders: A Comprehensive Review. Disease-a-Month. 67(7). 101130–101130. 50 indexed citations
9.
Belle, Jad I., Jessica C. Petrov, Yun Lin, et al.. (2020). MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction. JCI Insight. 5(13). 14 indexed citations
10.
Yan, Lulu, Hongyu Zhang, M. Wada, et al.. (2020). Targeting Two Antigens Associated with B-ALL with CD19-CD123 Compound Car T Cell Therapy. Stem Cell Reviews and Reports. 16(2). 385–396. 21 indexed citations
11.
Salman, Huda, Kevin G. Pinz, M. Wada, et al.. (2019). Preclinical Targeting of Human Acute Myeloid Leukemia Using CD4-specific Chimeric Antigen Receptor (CAR) T Cells and NK Cells. Journal of Cancer. 10(18). 4408–4419. 34 indexed citations
12.
Petrov, Jessica C., M. Wada, Kevin G. Pinz, et al.. (2018). Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia. Leukemia. 32(6). 1317–1326. 92 indexed citations
13.
Chen, Kevin H., M. Wada, Kevin G. Pinz, et al.. (2017). A compound chimeric antigen receptor strategy for targeting multiple myeloma. Leukemia. 32(2). 402–412. 66 indexed citations
14.
Petrov, Jessica C., et al.. (2017). A role for the histone H2A deubiquitinase MYSM1 in maintenance of CD8+ T cells. Immunology. 151(1). 110–121. 13 indexed citations
15.
Petrov, Jessica C. & Anastasia Nijnik. (2016). Mysm1 expression in the bone marrow niche is not essential for hematopoietic maintenance. Experimental Hematology. 47. 76–82.e3. 7 indexed citations
16.
Belle, Jad I., Jessica C. Petrov, David Langlais, et al.. (2016). Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance. Cell Death and Differentiation. 23(5). 759–775. 52 indexed citations
17.
Petrov, Jessica C., Jad I. Belle, Barbara C. Mindt, et al.. (2016). MYSM1-dependent checkpoints in B cell lineage differentiation and B cell–mediated immune response. Journal of Leukocyte Biology. 101(3). 643–654. 14 indexed citations
18.
Belle, Jad I., et al.. (2015). Deubiquitinase MYSM1 Is Essential for Normal Fetal Liver Hematopoiesis and for the Maintenance of Hematopoietic Stem Cells in Adult Bone Marrow. Stem Cells and Development. 24(16). 1865–1877. 19 indexed citations
19.
Petrov, Jessica C.. (1970). Quasi-hydrocephalic arterio-venous dissonance in corpus callosum tumours. Neuroradiology. 1(4). 228–232. 1 indexed citations
20.
Todorov, Atanas & Jessica C. Petrov. (1969). [Development and changes in skeletal muscle fiber (differentiation, hyperplasia and physiological degeneration) in pigs following birth].. PubMed. 125(1). 88–108. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rafet Başar Breakdown of academic impact, for papers by Rui Cui Breakdown of academic impact, for papers by Giulia Mesiano Breakdown of academic impact, for papers by Sasan Ghaffari Breakdown of academic impact, for papers by Zhongxing Jiang Breakdown of academic impact, for papers by David Stroncek Breakdown of academic impact, for papers by A. Rietz Breakdown of academic impact, for papers by Elham Roshandel Breakdown of academic impact, for papers by Saada Eid Breakdown of academic impact, for papers by Shengkang Huang
Rankless by CCL
2026